MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, GLUE has $459,841K in assets. $214,004K in debts. $208,343K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
653.97%
Cash Ratio
339.08%
Debt to Asset Ratio
46.54%
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Total property and equipment, at...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue, net of current
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
208,343 69,429
Marketable securities
182,915 221,165
Other receivables
4,965 2,370
Prepaid expenses and other current assets
5,594 6,501
Total current assets
401,817 299,465
Total property and equipment, at cost
53,122 -
Less accumulated depreciation
25,524 -
Property and equipment, net
27,598 29,052
Operating lease right-of-use assets
25,065 25,674
Restricted cash
4,950 4,950
Other long-term assets
411 445
Total assets
459,841 359,586
Accounts payable
14,509 5,581
Accrued expenses and other current liabilities
17,902 13,767
Current deferred revenue
24,791 18,410
Current portion of operating lease liability
4,241 4,094
Total current liabilities
61,443 41,852
Deferred revenue, net of current
111,894 8,059
Defined benefit plan liability
4,740 4,558
Operating lease liability, net of current
35,927 37,037
Total liabilities
214,004 91,506
Common stock, 0.0001 par value 500,000,000 shares authorized, 61,790,239 and 61,507,446 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively
6 6
Additional paid-in capital
680,157 675,445
Accumulated other comprehensive loss
-3,247 -3,373
Accumulated deficit
-431,079 -403,998
Total stockholders' equity
245,837 268,080
Total liabilities and stockholders' equity
459,841 359,586
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Total property andequipment, at cost$53,122K Prepaid expenses andother current assets$5,594K Other receivables$4,965K Marketable securities$182,915K Cash and cashequivalents$208,343K Other long-termassets$411K Restricted cash$4,950K Operating leaseright-of-use assets$25,065K Property and equipment,net$27,598K Total current assets$401,817K Less accumulateddepreciation$25,524K Total assets$459,841K Total liabilities andstockholders' equity$459,841K Total stockholders'equity$245,837K Total liabilities$214,004K Accumulated deficit-$431,079K Accumulated othercomprehensive loss-$3,247K Additional paid-in capital$680,157K Operating leaseliability, net of current$35,927K Defined benefit planliability$4,740K Deferred revenue, net ofcurrent$111,894K Total currentliabilities$61,443K Common stock, 0.0001par value...$6K Current portion ofoperating lease liability$4,241K Current deferredrevenue$24,791K Accrued expenses andother current...$17,902K Accounts payable$14,509K

Monte Rosa Therapeutics, Inc. (GLUE)

Monte Rosa Therapeutics, Inc. (GLUE)